RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/9285411http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/9285411http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/9285411http://www.w3.org/2000/01/rdf-schema#comment"The human cytomegalovirus UL18 gene product is a homolog of cellular major histocompatibility (MHC) class I antigens. UL18 has been proposed to protect virus-infected cells against natural killer (NK) cell cytotoxicity by engaging NK cell killer inhibitory receptors (KIR) for MHC class I. UL18 binds to a novel immunoglobulin superfamily glycoprotein, designated Leukocyte Immunoglobulin-like Receptor (LIR-1). This protein is distinct from, but related to, known KIRs and binds cellular MHC class I antigens. The cytoplasmic domain of LIR-1 contains four putative immunoreceptor tyrosine-based inhibitory motifs. Upon tyrosine phosphorylation, LIR-1 associates with the tyrosine phosphatase SHP-1. In contrast to KIRs, LIR-1 is expressed predominantly on monocytic and B lymphoid cell types, suggesting a distinct biological function."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.org/dc/terms/identifier"doi:10.1016/s1074-7613(00)80529-4"xsd:string
http://purl.uniprot.org/citations/9285411http://purl.org/dc/terms/identifier"doi:10.1016/s1074-7613(00)80529-4"xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Kubin M."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Kubin M."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Peterson L."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Peterson L."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Chin W."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Chin W."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Cosman D."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Cosman D."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Borges L."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Borges L."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Fanger N."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Fanger N."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Hsu M.-L."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/author"Hsu M.-L."xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/date"1997"xsd:gYear
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/date"1997"xsd:gYear
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/name"Immunity"xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/name"Immunity"xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/pages"273-282"xsd:string
http://purl.uniprot.org/citations/9285411http://purl.uniprot.org/core/pages"273-282"xsd:string